/C O R R E C T I O N - AbbVie/
/C O R R E C T I O N - AbbVie/PR NewswireNORTH CHICAGO, Ill., Oct. 18, 2026In the news release, AbbVie to Present Data at the 2026 European Society for Medical
PRO - PROS Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$29.05
DETAILS
HIGH:
$39.00
LOW:
$22.00
MEDIAN:
$30.00
CONSENSUS:
$29.05
UPSIDE:
24.95%
Stock News
AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio
AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor PortfolioPR News
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 '304' Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern
ESC 2026 Research Underscores the Burden of PSVT, Everest Medicines' CARDAMYST(R) Offers an Out-of-Hospital, Self-Administered Treatment Option
HONG KONG, Sept 21, 2026 - (ACN Newswire) - Everest Medicines announced findings from a longitudinal study describing how paroxysmal supraventricular tachycardi
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) acro
Price Targets
Pros Holdings downgraded to Market Perform from Outperform at Northland
$23.25
(was $22.92)
Nehal Chokshi
·
Northland Securities
Pros Holdings elevated to 'Top Pick' at Northland
$38.00
(was $18.04)
Northland Securities
Pros Holdings price target lowered to $22 from $31 at KeyBanc
$22.00
(was $16.43)
Jason Celino
·
KeyBanc
PROS Holdings (PRO) PT Raised to $30 at Baird
$30.00
(was $25.21)
Ron Oliver
·
Robert W. Baird
Pros Holdings price target lowered to $28 from $36 at KeyBanc
$28.00
(was $19.38)
Jason Celino
·
KeyBanc
Pros Holdings upgraded to Buy from Hold at Craig-Hallum
$31.00
(was $19.38)
Jeff Van Rhee
·
Craig-Hallum
Pros Holdings price target lowered to $39 from $43 at BofA
$39.00
(was $19.15)
Victor Cheng
·
Bank of America Securities
KeyBanc Upgrades PROS Holdings (PRO) to Overweight
$43.00
(was $35.18)
Jason Celino
·
KeyBanc